US Patent Issued to The Board of Regents of the University of Oklahoma, Oklahoma Medical Research Foundation on Nov. 11 for "Peripheral blood DNA methylation models as predictors of knee osteoarthritis radiographic progression" (Oklahoma Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,092, issued on Nov. 11, was assigned to The Board of Regents of the University of Oklahoma (Norman, Okla.) and Oklahoma Medical Research Foundation (Oklahoma City).

"Peripheral blood DNA methylation models as predictors of knee osteoarthritis radiographic progression" was invented by Matlock Jeffries (Oklahoma City).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method for determining whether a subject diagnosed with osteoarthritis is at increased risk for progression to severe osteoarthritis within 12-24 months, the method comprising the steps of: (a) preparing a blood sample; (b) measuring in the blood sample prepar...